Xinglou Chengqi Granule for recent ischemic stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a traditional Chinese medicine granule called Xinglou Chengqi. It is for people who had an ischemic stroke (blocked blood vessel in the brain) within the last 7 days and have certain symptoms. The goal is to see if it helps recovery and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an ischemic stroke (a stroke caused by a blocked blood vessel) within the last 7 days.
- You are between 18 and 70 years old.
- Your stroke symptoms are moderate (not too mild or too severe).
- You have not had or planned a clot-busting procedure (thrombolysis) or clot-removal surgery for this stroke.
- You can take the medicine by mouth and are capable of giving informed consent.
- You do not have severe liver or kidney problems, active cancer, or uncontrolled diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a traditional Chinese herb formula called Qingre Huatan to see if it can stop stroke symptoms from getting worse in the first few days. It is for people who have had an ischemic stroke within the last 48 hours and are at high risk for early decline.
This trial tests whether a traditional Chinese medicine (Angong Niuhuang pill) made from different sources of a natural ingredient can help people who recently had a moderate stroke caused by a blood clot. It aims to see if the pill can improve recovery.
This Phase 2 study tests LT3001 to improve recovery after an acute ischemic stroke (a stroke caused by blocked blood flow). It is designed for people who can be treated within 24 hours of symptom onset and who meet specific safety and health requirements.
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
This study tests whether a new drug called QD202 can help protect the brain and improve recovery when given alongside standard clot-busting therapy (thrombolysis) for acute ischemic stroke. You would be in the trial if you had a stroke in the last 24 hours and are receiving or planning to receive thrombolytic treatment.
This study tests a traditional Chinese medicine (herbal) treatment for people who have had a recent acute ischemic stroke. It will see if the herbal medicine helps improve recovery and how it works in the body, potentially offering a new treatment option.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.